156 related articles for article (PubMed ID: 24635061)
1. Utility of patch testing for patients with drug eruption.
Ohtoshi S; Kitami Y; Sueki H; Nakada T
Clin Exp Dermatol; 2014 Apr; 39(3):279-83. PubMed ID: 24635061
[TBL] [Abstract][Full Text] [Related]
2. Clinical spectrum of drug rashes due to antiepileptics.
Sharma VK; Vatve M; Sawhney IM; Kumar B
J Assoc Physicians India; 1998 Jul; 46(7):595-7. PubMed ID: 12152838
[TBL] [Abstract][Full Text] [Related]
3. Drug eruptions: the value of oral rechallenge test and patch test.
Puavilai S; Chunharas A; Kamtavee S; Pongwiriyapanich S
J Med Assoc Thai; 2002 Feb; 85(2):263-9. PubMed ID: 12081129
[TBL] [Abstract][Full Text] [Related]
4. Patch testing in fixed drug eruptions--a 20-year review.
Andrade P; Brinca A; Gonçalo M
Contact Dermatitis; 2011 Oct; 65(4):195-201. PubMed ID: 21702758
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactivity among p-amino group compounds in sulfonamide fixed drug eruption: diagnostic value of patch testing.
Tornero P; De Barrio M; Baeza ML; Herrero T
Contact Dermatitis; 2004 Aug; 51(2):57-62. PubMed ID: 15373844
[TBL] [Abstract][Full Text] [Related]
6. Topical provocation in 31 cases of fixed drug eruption: change of causative drugs in 10 years.
Lee AY
Contact Dermatitis; 1998 May; 38(5):258-60. PubMed ID: 9667442
[TBL] [Abstract][Full Text] [Related]
7. Topical provocation in fixed drug eruption due to metamizol and naproxen.
Ozkaya-Bayazit E
Clin Exp Dermatol; 2004 Jul; 29(4):419-22. PubMed ID: 15245546
[TBL] [Abstract][Full Text] [Related]
8. Patch testing and sensitization to multiple drugs.
Liippo J; Pummi K; Hohenthal U; Lammintausta K
Contact Dermatitis; 2013 Nov; 69(5):296-302. PubMed ID: 24117740
[TBL] [Abstract][Full Text] [Related]
9. Path test reactions to the Chinese Standard Screening Allergens in 1,135 patients investigated for allergic contact dermatitis.
Liu YQ; Zhao B; Zhuang LH; Fan WX
Am J Contact Dermat; 1997 Sep; 8(3):141-3. PubMed ID: 9249281
[TBL] [Abstract][Full Text] [Related]
10. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions.
Hassoun-Kheir N; Bergman R; Weltfriend S
Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159
[TBL] [Abstract][Full Text] [Related]
11. Patch testing in the detection of cutaneous reactions caused by carbamazepine.
Liao HT; Hung KL; Wang CF; Chen WC
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(5):365-9. PubMed ID: 9401180
[TBL] [Abstract][Full Text] [Related]
12. The usefulness of skin tests to prove drug hypersensitivity.
Lammintausta K; Kortekangas-Savolainen O
Br J Dermatol; 2005 May; 152(5):968-74. PubMed ID: 15888154
[TBL] [Abstract][Full Text] [Related]
13. Drug patch testing in systemic cutaneous drug allergy.
Barbaud A
Toxicology; 2005 Apr; 209(2):209-16. PubMed ID: 15767038
[TBL] [Abstract][Full Text] [Related]
14. Patch testing in cutaneous reactions caused by carbamazepine.
Alanko K
Contact Dermatitis; 1993 Nov; 29(5):254-7. PubMed ID: 8112065
[TBL] [Abstract][Full Text] [Related]
15. Eczematous-type multiple drug allergy from isoniazid and ethambutol with positive patch test results.
Özkaya E
Cutis; 2013 Sep; 92(3):121-4. PubMed ID: 24153138
[TBL] [Abstract][Full Text] [Related]
16. Positive patch test reactions to gentamicin show sensitization to aminoglycosides from topical therapies, bone cements, and from systemic medication.
Liippo J; Lammintausta K
Contact Dermatitis; 2008 Nov; 59(5):268-72. PubMed ID: 18976376
[TBL] [Abstract][Full Text] [Related]
17. Scratch-patch and patch testing in drug allergy--an assessment of specificity.
Hug K; Yawalkar N; Helbling A; Pichler WJ
J Investig Allergol Clin Immunol; 2003; 13(1):12-9. PubMed ID: 12861846
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous adverse drug eruption: the role of drug patch testing.
Thaiwat S; Rojanapanthu P
Int J Dermatol; 2023 Jan; 62(1):108-114. PubMed ID: 36300773
[TBL] [Abstract][Full Text] [Related]
19. Reproducible identification of the causative drug of a fixed drug eruption by oral provocation and lesional patch testing.
Zedlitz S; Linzbach L; Kaufmann R; Boehncke WH
Contact Dermatitis; 2002 Jun; 46(6):352-3. PubMed ID: 12190624
[No Abstract] [Full Text] [Related]
20. Is drug allergy less prevalent than previously assumed? A 5-year analysis.
Heinzerling LM; Tomsitz D; Anliker MD
Br J Dermatol; 2012 Jan; 166(1):107-14. PubMed ID: 21916887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
